Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell-surface receptors and attachment factors are a heterogeneous class of molecules—including glycoproteins, glycolipids, and glycosaminoglycans—that serve as the primary interface for pathogen docking and internalization. Attachment factors, such as heparan sulfate proteoglycans (HSPGs), facilitate the initial, often non-specific, recruitment of pathogens to the cell surface, increasing the local concentration of infectious agents (Maginnis, 2018). In contrast, entry receptors are highly specific molecules, such as Angiotensin-converting enzyme 2 (ACE2) for SARS-CoV-2 or CD4 for HIV-1, that undergo or induce conformational changes necessary for membrane fusion or endocytosis (Marsh & Helenius, 2006). These molecules are essential for the initiation of the infectious cycle, making them significant targets for antiviral and antibacterial therapies. Targeting these host factors is a key strategy in developing host-directed therapies, which may offer a higher barrier to resistance compared to drugs targeting rapidly mutating viral proteins (Shehu et al., 2022). However, because these molecules typically perform vital physiological roles, such as blood pressure regulation or immune signaling, pharmacological modulation carries risks of systemic toxicity and functional impairment (Baranowski et al., 2001). Current therapeutic examples include CCR5 antagonists like Maraviroc, which prevent HIV entry by blocking the coreceptor required for viral fusion.
Competitive inhibition of pathogen binding sites, allosteric modulation of host receptor conformation to prevent membrane fusion, or enzymatic modification of attachment factors to reduce pathogen affinity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host cell-surface receptors and attachment factors.